Industry association says Sweden ought to capitalize more on life science innovation
Sweden must become better at leveraging its life science innovation and research to halt foreign investors from taking advantage of the value created in the country, says IML, a Swedish life science organization.
While Sweden’s life science industry is a good innovator, producing a huge amount of research, it needs to improve when it comes to turning knowledge into action, says Johan Järte, managing director of Swedish life science association IML, as reported by national media Biostock.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Stockholm wants to become leading life science region
For subscribers
.jpg)
.jpg&w=384&q=75)
